Live Breaking News & Updates on Patient Engagement Advisory Committee Meeting Announcement Oct

The U.S. Food and Drug Administration (“FDA”) has announced its first-ever draft guidance specifically addressing the use of artificial intelligence/machine learning (“AI/ML”) in. ....

White House , District Of Columbia , United States , Paul Clowes , Nelson Mullins , Patient Engagement Advisory Committee Meeting Announcement Oct , Drug Administration , Nelson Mullins Riley Scarborough , Nelson Mullins Riley , Drug Omnibus Reform Act , Federal Food , Cosmetic Act , Predetermined Change Control Plans , Draft Guidance , Premarket Approval , Implement Device , Modification Protocol , Evolving Role , Artificial Intelligence , Radiological Imaging , Public Workshop , Machine Learning Enabled Medical Devices , Machine Learning , Based Software , Medical Device , Action Plan ,